Author name: giuseppe.cantoni.marketer@gmail.com

Parallel importation of medicines is an issue of great interest to pharmaceutical stakeholders, particularly importers, distributors, and pharmacies operating in an increasingly competitive and regulated environment. In Switzerland, this practice is permitted but subject to strict requirements set by Swissmedic and the federal regulatory framework. Understanding what is actually allowed and what the critical issues […]

In the Swiss regulatory environment for medical devices and regulated products, the position of Technical Responsible (RT) is central to ensuring compliance with Swissmedic requirements and the safety of products placed on the market. The term Responsible Person is sometimes used as an international reference, but in the Swiss context the correct designation is Responsible

Medical device traceability is now one of the central elements of regulatory compliance in Switzerland. With the entry into force of the new Swiss regulations aligned with the European framework, the Unique Device Identification (UDI) system has become a mandatory tool to ensure unique identification, patient safety and post-marketing surveillance. For manufacturing companies, manufacturers and

In the life sciences sector, quality does not end with the production of the drug. Distribution also plays a crucial role in ensuring that products reach the end patient in a safe, effective and regulatory compliant condition. It is in this context that GDP – Good Distribution Practice, a set of basic requirements for the

The market for nutraceuticals in Switzerland is growing steadily, driven by consumers who are increasingly focused on prevention, wellness, and quality ingredients. However, accessing this market requires a thorough understanding of Swiss regulations, particularly product classification, labeling, and regulatory obligations. This article provides a practical and up-to-date overview designed for nutraceutical companies and supplement manufacturers

A practical approach for pharmacies and life science companies Quality audits are a crucial time for pharmacies, pharmaceutical companies and life science entities. They are not just about demonstrating compliance with regulatory requirements or reference standards, but about verifying the effectiveness of internal processes and the soundness of the management system adopted. Structured and knowledgeable

What the MDR Regulation entails for manufacturers, importers and distributors in Switzerland “Compliance is not an administrative goal, but the foundation of trust in the market.” With the entry into force of Regulation (EU) 2017/745(MDR), the medical device industry has undergone one of the most profound regulatory changes in decades. For Swiss companies-manufacturers, importers, and

Introduction In Switzerland, the pharmacy is not only a point of dispensing medicines, but a true health care advice center. To ensure high standards of safety, efficiency and reliability, pharmacies must implement quality management systems (QMS ) that comply with federal and cantonal regulations. These systems provide a structured basis for ensuring that every process-from

Swissdamed – UDI Devices Module As of Aug. 18, 2025, Swissmedic activated the UDI Devices module in the Swissdamed database, allowing voluntary registration of medical devices, IVDs, and kit/process packs (SPPs).From July 1, 2026, however, registration will become mandatory for all products placed on the Swiss market.There is also a short transition period until December

Why participate? The life-sciences industry is constantly evolving, and staying up-to-date on regulations and market trends is crucial, especially for pharmacies. This free webinar, organized by Pharmanomos Sagl in collaboration with AFTI (on the occasion of its 40th anniversary), provides a clear and up-to-date overview of topics critical to your business. Main topics of the